Lipid Metabolic Rewiring in Cancer Drug Resistance: Pathways, Networks, and Therapeutic Strategies

Drug resistance limits cancer therapy, and metabolic reprogramming helps tumor cells adapt to therapeutic stress. This review examines how altered lipid uptake, synthesis, storage, and oxidation support survival by changing signaling, membrane composition, energy production, redox balance, and tumor-microenvironment interactions. The SCAP/SREBP axis is a key transcriptional regulator; oncogenic and nutrient signaling (EGFR, PI3K/AKT/mTOR, mutant p53) controls SREBP abundance and activation, and sustained SREBP activity during treatment distinguishes resistant from sensitive cells in several models, including gefitinib-resistant lung cancer and sorafenib/lenvatinib-resistant hepatocellular carcinoma (HCC). MicroRNAs regulate these pathways post-transcriptionally, including ferroptosis-related targets (ACSL4, SLC7A11, GPX4). Inhibitors of lipogenesis, SCAP/SREBP, cholesterol metabolism, fatty-acid oxidation, lipid uptake and storage, phospholipid and sphingolipid signaling, and ferroptosis have improved drug sensitivity in preclinical models. However, many studies show only an association with resistance rather than that modulating a pathway restores sensitivity; findings vary between tumor types; and compensatory rewiring, toxicity, and limited tumor selectivity constrain single-target approaches, while miRNA-based therapeutics remain early-stage. Rational combinations guided by lipidomic and transcriptomic profiling are a priority.

Authors

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-17
DOI
https://doi.org/10.3390/ijms272210316
Primary Topic
Cancer, Lipids, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Lipid Metabolic Rewiring in Cancer Drug Resistance: Pathways, Networks, and Therapeutic Strategies

Sukkum Ngullie Chang, Chiara Raggi, Vernat Exil
International Journal of Molecular Sciences
Cancer, Lipids, and Metabolism
article

Lipid Metabolic Rewiring in Cancer Drug Resistance: Pathways, Networks, and Therapeutic Strategies

Sukkum Ngullie Chang, Chiara Raggi, Vernat Exil
article en

Abstract

Drug resistance limits cancer therapy, and metabolic reprogramming helps tumor cells adapt to therapeutic stress. This review examines how altered lipid uptake, synthesis, storage, and oxidation support survival by changing signaling, membrane composition, energy production, redox balance, and tumor-microenvironment interactions. The SCAP/SREBP axis is a key transcriptional regulator; oncogenic and nutrient signaling (EGFR, PI3K/AKT/mTOR, mutant p53) controls SREBP abundance and activation, and sustained SREBP activity during treatment distinguishes resistant from sensitive cells in several models, including gefitinib-resistant lung cancer and sorafenib/lenvatinib-resistant hepatocellular carcinoma (HCC). MicroRNAs regulate these pathways post-transcriptionally, including ferroptosis-related targets (ACSL4, SLC7A11, GPX4). Inhibitors of lipogenesis, SCAP/SREBP, cholesterol metabolism, fatty-acid oxidation, lipid uptake and storage, phospholipid and sphingolipid signaling, and ferroptosis have improved drug sensitivity in preclinical models. However, many studies show only an association with resistance rather than that modulating a pathway restores sensitivity; findings vary between tumor types; and compensatory rewiring, toxicity, and limited tumor selectivity constrain single-target approaches, while miRNA-based therapeutics remain early-stage. Rational combinations guided by lipidomic and transcriptomic profiling are a priority.

International Journal of Molecular SciencesVol. 27(22)
Good health and well-being
Cancer, Lipids, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon